AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimilio M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alio Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimilio M 1mg/500mg Tablet

DiaBeta Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can lead to dangerously elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, and always carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or lactating women must consult their doctor prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimilio M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimilio M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. It's recommended to take Glimilio M 1mg/500mg Tablet with a meal.

Common Side effects of Glimilio M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilio M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimilio M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Glimilio M 1mg/500mg Tablet works:

Glimilio M 1mg/500mg tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimilio M 1mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimilio M 1mg/500mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Glimilio M 1mg/500mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Operating a vehicle may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimilio M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. The use of Glimilio M 1mg/500mg tablets is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilio M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimilio M 1mg/500mg Tablet :

Should you forget to take your Glimilio M 1mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glimilio M 1mg/500mg Tablet

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Glimilio M 1mg/500mg Tablet

Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glimilio M 1mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms develop, discontinue Glimilio M 1mg/500mg Tablet use and seek immediate medical attention.
Glimilio M 1mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes mellitus.
Glimilio M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment might result in vitamin B12 deficiency.
Indeed, prolonged Glimilio M 1mg/500mg Tablet consumption can lead to Vitamin B12 deficiency. This medication impairs the stomach's absorption of Vitamin B12. Left unaddressed, this deficiency might result in anemia, neurological complications, including tingling and numbness in the extremities, muscular weakness, bladder dysfunction, cognitive impairment, and balance difficulties (ataxia). To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Indeed, Glimilio M 1mg/500mg Tablets may induce hypoglycemia (low blood glucose). Characteristic symptoms include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimilio M 1mg/500mg tablets and alcohol is unsafe. Alcohol consumption may exacerbate a drop in blood sugar, potentially causing hypoglycemia, and elevates the risk of lactic acidosis.
Glimilio M 1mg/500mg Tabl...
28
MRP 34
17% off